We search and select target products that come from overseas, then apply IDL. And all cost during the application including cost of clinical trial is invested by both our company and foreign company. We will play the roles of products' sale as the general agent in China when IDL is approved.

We have established good cooperation relationship with many manufacturers overseas, such as manufacturers in Korea, Italy, Germany and India. Parts of cooperation manufacturers overseas are as below:

     Pro.bio.sints.s.p.a. (Euticals Group, Italy)
     Jesalis Pharma GmbH. (Germany)
     CKD Bio Corporation. (Korea)
     Kyongbo Pharmaceutical Co., Ltd. (Korea)
     CJ Group. (Korea)
     Dongkook Pharmaceutical Co., Ltd. (Korea)
     Yungjin Pharm Co., Ltd. (Korea)
     Yuhan Corporation. (Korea)
     Hanall Pharmaceutical. (korea)
     Claris Lifesciences Pharmaceuticals Ltd. (India)
     Aurobindo Pharma Ltd. (India)
     Ranbaxy Laboratories Ltd. (India)
     Glenmark Pharmaceuticals Ltd. (India)

  What value can we create for our partners?